✦ LIBER ✦

Combination chemotherapy for Hodgkin's lymphoma during pregnancy: Favorable outcome for mother and child

✍ Scribed by Dariusz Sagan; Andrzej Semczuk; Elżbieta Lampka

Book ID: 109007315
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 263 KB
Volume: 36
Category: Article
ISSN: 1341-8076
DOI: 10.1111/j.1447-0756.2010.01249.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Asystole during combination chemotherapy

Asystole during combination chemotherapy for non-Hodgkin’s lymphoma: the acute tumor lysis syndrome

✍ Johan M Van Der Klooster; Hans E Van Der Wiel; Jan L.C.M Van Saase; Albert F Gro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Combined Modality Treatment for PET-Posi

Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma: Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET

✍ Lia M. Halasz; Heather A. Jacene; Paul J. Catalano; Annick D. Van den Abbeele; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 414 KB

An alternating chemotherapy combination

An alternating chemotherapy combination (macoble) for intermediate and high-grade non-hodgkin's lymphoma

✍ M. Harding; L. McNulty; J. Paul; F. Lee; D. Dunlop; M. Soukop 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (MACOBLE). Their median age was 59 years, 20 (42 per cent) had an ECOG performance s

NHL-3 protocol six-drug combination chem

NHL-3 protocol six-drug combination chemotherapy for non-hodgkin's lymphoma

✍ Benjamin Koziner; Robert Sklaroff; Claudia Little; David J. Straus; Burton J. Le 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Alternating six-drug combination chemoth

Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma

✍ John A. Green; R. Douglas Errington; John R. G. Nash; Michael A. Coe; Hilmar M. 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 334 KB

Evolution of neuropathy and myopathy dur

Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphoma

✍ Lisa M. Deangelis; Claire Gnecco; Lynne Taylor; Raymond P. Warrell Jr 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB